Terms: = Uterine cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2
35190 results:
1. Trends in Early-Stage Cervical cancer Management in the US: A National cancer Database Analysis.
Wolf J; Wu Y; Hayek J; Zhang Q; Alagkiozidis I
Curr Oncol; 2024 May; 31(5):2836-2845. PubMed ID: 38785496
[TBL] [Abstract] [Full Text] [Related]
2. [A multicenter study on the accuracy of PAX1/JAM3 dual genes methylation testing for screening cervical cancer].
Shang X; Kong LH; Xiao XP; Wan R; Wang J; Wu HW; Chen XY; Shou HF; Fei J; Zhou JW; Lang JH; Li L
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1852-1859. PubMed ID: 38782754
[No Abstract] [Full Text] [Related]
3. Diagnostic and therapeutic challenges in a recurrent endometrial carcinoma in lung, 15 years after primary treatment.
Upadhyay AK; Kumar M; Prakash A; Kumar A
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38782427
[TBL] [Abstract] [Full Text] [Related]
4. Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
Broshkevitch CJ; Barnabas RV; Liu G; Palanee-Phillips T; Rao DW
PLoS One; 2024; 19(5):e0301997. PubMed ID: 38781268
[TBL] [Abstract] [Full Text] [Related]
5. Long-term outcome and fertility results of intraplacental choriocarcinoma: a retrospective study of 14 patients and literature review.
Liu Y; Song X; Zhang H; Feng F; Zhao J; Yang J; Ren T; Wan X; Jiang F; Li Y; Xiang Y
Orphanet J Rare Dis; 2024 May; 19(1):214. PubMed ID: 38778412
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Outcomes and Dosimetric Evaluationof Interstitial Brachytherapyin Gynecological Malignancies.
V VN; Dharmarajan A; Jones J; Yahiya EKN; Muttath G; Sneha N
Gulf J Oncolog; 2024 May; 1(45):69-74. PubMed ID: 38774935
[TBL] [Abstract] [Full Text] [Related]
7. Scelte gestionali per sostenere e migliorare i programmi di screening oncologico.
Chiereghin A; Squillace L; Pizzi L; Sanna T; Bazzani C; Roti L; Mezzetti F
Epidemiol Prev; 2024; 48(2):158-164. PubMed ID: 38770733
[TBL] [Abstract] [Full Text] [Related]
8. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
[TBL] [Abstract] [Full Text] [Related]
9. Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
Xiao Y; Zhi Y; Cao G; Ma H; Gao J; Li F
J Cancer Res Clin Oncol; 2024 May; 150(5):267. PubMed ID: 38769118
[TBL] [Abstract] [Full Text] [Related]
10. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
Liu Y; Shi W; Mubarik S; Wang F
BMC Public Health; 2024 May; 24(1):1349. PubMed ID: 38764017
[TBL] [Abstract] [Full Text] [Related]
11. Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study.
Kabanda R; Kiconco A; Ronald A; Beyer KMM; John SA
BMC Womens Health; 2024 May; 24(1):296. PubMed ID: 38762723
[TBL] [Abstract] [Full Text] [Related]
12. Achieving NPVR ≥ 80% as technical success of high-intensity focused ultrasound ablation for uterine fibroids: a cohort study.
Li S; Yang M; Yu J; Ma W; Deng Y; Hu L; Chen JY
BMC Womens Health; 2024 May; 24(1):294. PubMed ID: 38762488
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
Dong B; Zhou SF
BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
[TBL] [Abstract] [Full Text] [Related]
14. Validation of the Amharic version of perceived access to healthcare services for patients with cervical cancer in Ethiopia: A second-order confirmatory factor analysis.
Shimels T; Gashawbeza B; Fenta TG
PLoS One; 2024; 19(5):e0300815. PubMed ID: 38748736
[TBL] [Abstract] [Full Text] [Related]
15. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of cancer screening services provided for people living with HIV in Botswana, 2022-2023.
Mathoma A; Sartorius B; Mahomed S
Health Promot Int; 2024 Jun; 39(3):. PubMed ID: 38742893
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
[TBL] [Abstract] [Full Text] [Related]
18. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
[TBL] [Abstract] [Full Text] [Related]
19. Culturally Competent Education and Human Papillomavirus Self-Sampling Achieves Healthy People 2030 Cervical Screening Target Among Low-Income Non-Hispanic Black and Hispanic Women.
Shastri SS; McNeill LH; Shete S
JCO Glob Oncol; 2024 May; 10():e2400005. PubMed ID: 38723214
[TBL] [Abstract] [Full Text] [Related]
20. TPP1 is associated with risk of advanced precursors and cervical cancer survival.
Wang QL; Gong C; Meng XY; Fu M; Yang H; Zhou F; Wu Q; Zhou Y
PLoS One; 2024; 19(5):e0298118. PubMed ID: 38722833
[TBL] [Abstract] [Full Text] [Related]
[Next]
